The notices it replaced
- Reissues: PAR-12-123 NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)
Replaced by PAR-18-340.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,345,250 in first-year total cost, median $658,484.
Most frequent study sections
- Special Emphasis Panel[ZDC1 SRB-L (49)]2
- Special Emphasis Panel[ZDC1 SRB-L (50)]2
- Special Emphasis Panel[ZDC1 SRB-K (19)]1
- Special Emphasis Panel[ZDC1 SRB-L (44)]1
- Special Emphasis Panel[ZDC1 SRB-L (46)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- MONELL CHEMICAL SENSES CENTER1
- UNIVERSITY OF ALABAMA IN TUSCALOOSA1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
- UNIVERSITY OF MINNESOTA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Maximizing outcomes for preschoolers with developmental language disorder: testing the effects of a sequentially targeted naturalistic intervention1U01DC017135-01 | HADLEY, PAMELA AKAISER, ANN P.ROBERTS, MEGAN Y | VANDERBILT UNIVERSITY, TN | $1,237,542 | ZDC1 |
| 2018 | Diet-induced modification of sweet taste perception and preference: A potential strategy to aid in population-wide reduction in sugar intake1U01DC017130-01 | BEAUCHAMP, GARY KWISE, PAUL M | MONELL CHEMICAL SENSES CENTER, PA | $566,924 | ZDC1 |
| 2017 | COCHLEAR IMPLANTATION IN ADULTS WITH ASYMMETRIC HEARING LOSS CLINICAL TRIAL1U01DC014938-01A1 | FIRSZT, JILL B | WASHINGTON UNIVERSITY, MO | $676,487 | ZDC1 |
| 2015 | Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media1U01DC013995-01A1 · under PAR-12-123 | HOBERMAN, ALEJANDROPRECIADO, DIEGO | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $967,885 | ZDC1 |
| 2015 | Tinnitus Retraining Therapy Trial (TRTT)2U01DC007411-06 · under PAR-12-123 | FORMBY, CHARLES CRAIG | UNIVERSITY OF ALABAMA IN TUSCALOOSA, AL | $350,000 | ZDC1 |
| 2015 | Tinnitus Retraining Therapy Trial2U01DC007422-06 · under PAR-12-123 | SCHERER, ROBERTA W | JOHNS HOPKINS UNIVERSITY, MD | $182,116 | ZDC1 |
| 2014 | AVERT_Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage1U01DC013778-01A1 · under PAR-12-123 | NEWMAN-TOKER, DAVID | JOHNS HOPKINS UNIVERSITY, MD | $1,163,935 | ZDC1 |
| 2014 | A Phase II Trial on Rizatriptan for Vestibular Migraine1U01DC013256-01A1 · under PAR-12-123 | BALOH, ROBERT WILLIAMSTAAB, JEFFREY PAUL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $658,484 | ZDC1 |
| 2014 | Phase I safety study for a new two-shank auditory midbrain implant (AMI)1U01DC013030-01A1 · under PAR-12-123 | LENARZ, THOMASLIM, HUBERT HYUNGILPATRICK, JAMES FINLAY | UNIVERSITY OF MINNESOTA, MN | $541,877 | ZDC1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.